US10548859 — Methods for storing Cysteamine formulations and related methods of treatment
Method of Use · Assigned to Horizon Orphan LLC · Expires 2036-08-16 · 10y remaining
What this patent protects
This patent provides methods for storing, stabilizing, distributing, and treating cystinosis using pharmaceutical compositions containing cysteamine or a pharmaceutically acceptable salt thereof.
USPTO Abstract
Methods of storing and methods of stabilizing pharmaceutical compositions comprising cysteamine, or a pharmaceutically acceptable salt thereof, are provided. Methods of distributing pharmaceutical compositions comprising cysteamine, or a pharmaceutically acceptable salt thereof, and methods of treating cystinosis also are provided.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1399 |
— | cysteamine-bitartrate |
U-1399 |
— | cysteamine-bitartrate |
U-1399 |
— | cysteamine-bitartrate |
U-1399 |
— | cysteamine-bitartrate |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.